Chances do detect cancer ealry
 
Geneva:
+4122 840 33 34
 
Moscow:
+7(903)720 80 57

An early detection of pancreatic cancer

According to a study, the presence of three proteins in urine can be used to detect some early stage pancreatic cancer with over 90% accuracy.

High levels of a combination of three proteins in urine seem to be a good indicator of pancreatic cancer in early stages of development, according to British researchers. Their study, published in the United States offers hope for early detection.

Combined, these three proteins can be used to detect some advanced pancreatic cancer with over 90% accuracy, they said. They also reiterated that there is currently no test for early detection of this tumor.

The discovery could pave the way for a non-invasive and inexpensive screening of people considered at high risk of developing this very aggressive cancer. Symptoms of this cancer occur most often when it is already very advanced and that surgery is no longer useful.

The research team from Barts Cancer Institute, fromQueen Mary University in London, analyzed urine samples from 488 people, including 192 already diagnosed with pancreatic cancer, 92 suffering from pancreatitis and 87 that were healthy. Researchers also analyzed 117 other patients urine samples with other benign liver disease or liver cancer and gall bladder problems.

The analyzed urine contained about 1,500 proteins. Proteins called LYVE1, REG1A and TFF1, were selected to be further investigated.

Patients with pancreatic cancer had significantly higher levels of each of these three proteins in their urine compared to people in good health. Patients with chronic pancreatitis had significantly lower levels than those with cancer, the researchers found.

With few specific symptoms of pancreatic cancer manifested even at an advanced stage of the disease, it is already widespread in more than 80% of patients at diagnosis. Therefore, they can not be operated to withdraws the tumor that has spread.

The survival rate at five years for pancreatic cancer is 3%, the lowest of all cancers. This rate has barely improved in 40 years.

Although there is no known universal cause of pancreatic cancer, those considered to have a greater risk have a family history of the disease, are heavy smokers, obese or became diabetic after 50 years.

Comments
Articles
Patient registration form
Topics
Examination Incorpore
nutrition
oncology
prevention
cancer
dermatology
age management
Anti-aging
detoxification
skin
heavy metal
diagnosis
cardiology
immunology
stem cells
weight management
oncology treatment
liver detox
DNA
Genetics
allergy
pain
Fertility
Examination partner centres
gastroenterology
covid19
weight loss
cosmetology
liver
infertility
chelation
Sleep
gynecology
urology
radiology
neurology
check-up
skincare
pregnancy
Hepatitis C
rehabilitation
headache
breast cancer
candida
arsenic
anti-aging
obstetrics
joints
immune system
Дерматология
heart MRI
immunotherapy
NAD+
Blood pressure
mesotherapy
probiotics
Apnea
tinnitus
ulcer
abdominal pain
pancreas
research
sexuality
beau-rivage
nutrigenomics
migraine
menopause
telomere
gastritis
flu vaccine
regeneration
PRP
andropause
light therapy
excimer laser
psoriasis
hyaluronic acid
sugar
obstertics
rhesus factor
Allergology
preventiion
gastroscopy
brain surgery awake
mastectomy
digestion
mammography
cellmen
cellcosmet
herniated disc
flu
magnesium
R-loops
Omega-3
shoulder
hand
intestinal flora
depression
iron
second opinion
food intolerances
reflexology
food
vitamin b12
mercury
water
erectile dysfunction
back pain
hip
knee
beauty
exercise
sports
cholesterol
stress
vitamin K
narcosis
diabetes
cellulite
acnea
migraines
chronic headaches
diet
oncoloy
reconstruction
blood test
endometriosis
acne
LED therapy
biopsy
liquid biopsy
oral checkup
propofole
dermatitis
hormones
general surgery
nephrology
kidney
ophthalmology
plastic surgery
lungs
pneumology
proctology
pomegranate
rheumatology
orthopedics
colonoscopy
endocrinology
Treatment programs